Increasing use of interferon gamma release assays among children ≥2 years of age in a setting with low tuberculosis prevalence
Loading...
Date
Authors
Campbell, Jeffrey I.
Tabatneck, Mary
Sun, Mingwei
He, Wei
Musinguzi, Nicholas
Hedt-Gauthier, Bethany
Lamb, Gabriella S.
Goldmann, Don
Sabharwal, Vishakha
Sandora, Thomas J.
Journal Title
Journal ISSN
Volume Title
Publisher
The Pediatric Infectious Disease Journal
Abstract
US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2–17 years of age increased substantially between 2015–2021. Testing in inpatient/subspecialty settings (vs primary care), public (vs private) insurance, lower age, and non-English preferred language were associated with increased odds of receiving an IGRA
Description
Citation
Campbell, J. I., Tabatneck, M., Sun, M., He, W., Musinguzi, N., Hedt-Gauthier, B., ... & Haberer, J. E. (2022). Increasing Use Of Interferon Gamma Release Assays Among Children≥ 2 Years of Age in a Setting With Low Tuberculosis Prevalence. The Pediatric Infectious Disease Journal, 41(12), e534-e537.